Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Chief Commercial Officer | June 24, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date June 24, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 309,630 |
Reported balance
After 2026-06-24 transaction · row 1
1 source rowRow 1 · 2026-06-24 · Tax withholding · Disposed 19,820 · Balance 309,630 F1: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2026 Filed Jun 25, 2026 20:20 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 19,820 | $3.83 | $75,910.60 |
DisclosureSEC source: 0001376339-26-000054 · wk-form4_1782418856.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,630 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 22:31 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 6,762 | $4.38 | $29,617.56 |
DisclosureSEC source: 0002029167-26-000006 · wk-form4_1773786668.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,450 F1 · shares: Shares withheld by the Company to satisfy tax withholding requirements on vesting of restricted stock. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:37 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 21,270 | $4.50 | $95,715.00 |
DisclosureSEC source: 0002029167-26-000004 · wk-form4_1773351421.xml · nonDerivative · entry 2 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,212 F2 · shares: The reported shares were sold in connection with the vesting of performance stock units (PSUs), as required by company policy, with shares withheld for payment of tax liability upon vesting. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 21:37 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Exercise / conversionCommon Stock | 42,845 | $4.50 | $192,802.50 |
DisclosureSEC source: 0002029167-26-000004 · wk-form4_1773351421.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 357,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2023 to December 31, 2025. The PSUs were granted on March 13, 2023. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:42 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 62,068 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0002029167-26-000002 · wk-form4_1772836942.xml · derivative · entry 2 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,862 Underlying: Common Stock · 62,068 shares Expires 2033-03-03 F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 22:42 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 74,163 | $0.00 | $0.00 |
DisclosureSEC source: 0002029167-26-000002 · wk-form4_1772836942.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,637 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. F2 · balance_after: Includes 3,492 shares acquired on January 30, 2026 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan. Read SEC document |
| November 06, 2025 Filed Nov 10, 2025 22:14 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 58,300 | $7.42 | $432,329.48 |
DisclosureSEC source: 0002029167-25-000008 · wk-form4_1762812880.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236,982 F1 · price: The price indicated is a weighted average price. The corresponding shares were sold in multiple transactions. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 20:48 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 12,034 | $5.96 | $71,722.64 |
DisclosureSEC source: 0001376339-25-000077 · wk-form4_1750970918.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,282 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 23:07 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 1,761 | $7.50 | $13,207.50 |
DisclosureSEC source: 0001628280-25-016665 · wk-form4_1743721613.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,316 F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units. Read SEC document |
| March 17, 2025 Filed Mar 20, 2025 10:09 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 1,759 | $8.04 | $14,142.36 |
DisclosureSEC source: 0001376339-25-000033 · wk-form4_1742465348.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,077 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 13, 2025 Filed Mar 14, 2025 21:56 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 4,106 | $7.89 | $32,396.34 |
DisclosureSEC source: 0001376339-25-000029 · wk-form4_1741989367.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,836 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantStock Options · Derivative | 36,486 | $0.00 Strike: $8.30 | $0.00 |
DisclosureSEC source: 0001376339-25-000025 · wk-form4_1741220002.xml · derivative · entry 3 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,794 Underlying: Common Stock · 36,486 shares Expires 2032-03-03 F4 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 45,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-25-000025 · wk-form4_1741220002.xml · nonDerivative · entry 2 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,942 F2 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. F3 · balance_after: Includes an aggregate of 3,742 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 28, 2025 Filed Mar 6, 2025 00:13 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 2,111 | $8.41 | $17,742.96 |
DisclosureSEC source: 0001376339-25-000025 · wk-form4_1741220002.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,271 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 22:02 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 125,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001376339-24-000067 · wk-form4_1734127313.xml · nonDerivative · entry 1 Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,382 F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.